No Data
No Data
10 Health Care Stocks With Whale Alerts In Today's Session
UBS Highlights 30 Stocks Poised for Potential Moves After the Fed's Expected Rate Cut
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
Moderna’s updated Covid-19 vaccine has been approved by the Canadian government.
Biotechnology company Moderna (MRNA.US) announced that after the United States, the Canadian government has approved its updated Covid-19 vaccine. The stock price rose 4.5% to $72.28 on Tuesday afternoon.